Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
Jesús Castilla, Óscar Lecea, Carmen Martín Salas, et al.
Eurosurveillance (2022) Vol. 27, Iss. 33
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 348-357
Open Access | Times Cited: 146
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS‐CoV‐2 in Exposed Individuals From Emilia Romagna Region and COVID‐19 Severity
L. Mazzotti, Patricia Borges de Souza, Irene Azzali, et al.
HLA (2025) Vol. 105, Iss. 1
Open Access
Longitudinal Follow‐Up of the Specific Antibody Response to SARS‐CoV‐2 Vaccination in Colombia
Myriam Arévalo‐Herrera, Bladimiro Rincón‐Orozco, John Mario González‐Escobar, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination
Daniel Hoffmann, Pieter Meyer, Catherine Worsley, et al.
Journal of Clinical Pathology (2025), pp. jcp-209722
Closed Access
Determinants and dynamics of the seroprevalence of anti‐SARS‐CoV‐2 antibodies in Poland
Justyna Adamczuk, Karol Kamiński, Sebastian Sołomacha, et al.
Advances in Medical Sciences (2025)
Closed Access
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
Loreto Núñez, Muriel Ramírez-Santana, Paola Rubilar, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 201-201
Open Access | Times Cited: 10
SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022
Géraldine Engels, Anna-Lisa Oechsle, Anne Schlegtendal, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1531-1539
Open Access | Times Cited: 9
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection—Final Update of a Living, Rapid Review
Haley K Holmer, Katherine Mackey, Celia Fiordalisi, et al.
Annals of Internal Medicine (2022) Vol. 176, Iss. 1, pp. 85-91
Open Access | Times Cited: 15
Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco
Sayeh Ezzikouri, Tajudeen Raji, Hind Majidi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
Sheila F. OʼBrien, Niamh Caffrey, Qilong Yi, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2336-2336
Open Access | Times Cited: 11
Seroprevalence of Anti-SARS-CoV-2 Antibodies Following the Omicron BA.1 Wave
Maja Sočan, Katarina Prosenc, Maja Mrzel
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3665-3665
Open Access | Times Cited: 5
Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022
In Hwa Jeong, Jong‐Hun Kim, Min‐Jung Kwon, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 5
Open Access | Times Cited: 1
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 58-58
Open Access | Times Cited: 1
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan
Seiya Yamayoshi, Etsuko Nagai, Keiko Mitamura, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access | Times Cited: 1
COVID-19 infections, hospitalizations, and mortality in Navarre (Spain) between February 2020 and September 2022
Itziar Casado, Manuel García Cenoz, Nerea Egüés, et al.
Anales del Sistema Sanitario de Navarra (2023) Vol. 46, Iss. 2
Open Access | Times Cited: 3
Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study
Iván Martínez‐Baz, Vanessa Bullón‐Vela, Núria Soldevila, et al.
JMIR Research Protocols (2023) Vol. 12, pp. e52114-e52114
Open Access | Times Cited: 3
COVID -19: On the threshold of the fifth year. The situation in Spain
Fernando Rodríguez‐Artalejo, Julián Ruiz‐Galiana, Rafael Cantón, et al.
Revista Española de Quimioterapia (2023) Vol. 37, Iss. 1, pp. 17-28
Open Access | Times Cited: 3
Trends in SARS-CoV-2 seroprevalence in Albania during the 2021–2022 pandemic year
Genc Sulcebe, Alban Ylli, Fabian Cenko, et al.
New Microbes and New Infections (2023) Vol. 56, pp. 101208-101208
Open Access | Times Cited: 3
Population-based sero-epidemiological estimates of real-world vaccine effectiveness against Omicron infection in an infection-naive population, Hong Kong, January to July 2022
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohort
Romain Fantin, Neha Agarwala, Amada Aparicio, et al.
The Lancet Regional Health - Americas (2023) Vol. 27, pp. 100616-100616
Open Access | Times Cited: 2
Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea
Hyun-Woo Choi, Chiara Achangwa, Joonhong Park, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023
Martynas Simanavičius, Indrė Kučinskaitė-Kodzė, Snieguolė Kaselienė, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29343-e29343
Open Access
Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort
Cynthia Porter, Zoë L. Lyski, Jennifer L. Uhrlaub, et al.
Diseases (2024) Vol. 12, Iss. 8, pp. 171-171
Open Access
Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study
Pere Godoy, Iván Martínez‐Baz, Ignasi Parrón, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 240-240
Open Access
Estrategia de vigilancia, detección y control de la COVID-19 en Navarra
Ma Ángeles Nuin, Álvaro Martín-Hernández, G. Larrosa Montañés, et al.
Gobierno de Navarra eBooks (2023), pp. 81-104
Open Access
Page 1 - Next Page

Scroll to top